Showing Form 4 filings for TAK
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Takeda Pharmaceutical Co Ltd
Price
$20.90
Shares
55,617
Ownership
270,253
Value/Share
Platford Giles Richard
Pres, IBU
Unknown
Industry
TAK
$18.54
34,535
191,522
Duprey Lauren Rusckowski
Chief Transformation Officer
$18.49
116,191
912,034
Plump Andrew Stewart
Pres, R, D
19,651
1,028,225
$18.11
12,980
40,049
Greenway Nicola Deidre Petal
CHRO
$17.10
7,277
102,588
Ibrahim Ramy Riad Ahmed
Pres, PDT BU
16,901
182,507
Pacheco Rhonda Janice
Pres, U.S. Business Unit
47,586
226,057
165,393
1,047,876
22,957
176,977
Pignagnoli Agosti Marcello
Head, Strat., Port. Dev
50,012
252,010
Bitetti Teresa Marie
Pres, OBU
3,978
63,333
Shannon Elaine Mary
Pres, Global Supply, Quality
14,006
116,177
Farajallah Awny Samaan Botros
Chief Medical Officer
6,774
53,029
89,090
391,489
Kim Julie So-Young
Pres, CEO
31,083
315,838
30,868
204,298
Furney Natalie Anne Marie
Global GC
$17.55
20,363
67,311
$17.51
34,603
59,803
25,088
171,654
Ricci Gabriele
Chief Data, Tech. Officer